Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

PURPOSE: Recent advances in nonmyeloablative (NMA), related HLA-haploidentical blood or marrow transplantation (haplo-BMT) have expanded the donor pool. This study evaluated the effect of age on NMA haplo-BMT outcomes in patients age 50 to 75 years. PATIENTS AND METHODS: A retrospective analysis was...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Oncol
Hoofdauteurs: Kasamon, Yvette L., Bolaños-Meade, Javier, Prince, Gabrielle T., Tsai, Hua-Ling, McCurdy, Shannon R., Kanakry, Jennifer A., Rosner, Gary L., Brodsky, Robert A., Perica, Karlo, Smith, B. Douglas, Gladstone, Douglas E., Swinnen, Lode J., Showel, Margaret M., Matsui, William H., Huff, Carol Ann, Borrello, Ivan, Pratz, Keith W., McDevitt, Michael A., Gojo, Ivana, Dezern, Amy E., Shanbhag, Satish, Levis, Mark J., Luznik, Leo, Ambinder, Richard F., Fuchs, Ephraim J., Jones, Richard J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2015
Onderwerpen:
ORIGINAL REPORTS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582145/
https://ncbi.nlm.nih.gov/pubmed/26261255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.60.4777
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items